TY  - GEN
AU  - David,D J
AU  - Klemenhagen,K C
AU  - Holick,K A
AU  - Saxe,M D
AU  - Mendez,I
AU  - Santarelli,L
AU  - Craig,D A
AU  - Zhong,H
AU  - Swanson,C J
AU  - Hegde,L G
AU  - Ping,X I
AU  - Dong,D
AU  - Marzabadi,M R
AU  - Gerald,C P
AU  - Hen,R
TI  - Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis
SN  - 0022-3565
PY  - 2007///0514
KW  - Animals
KW  - Anti-Anxiety Agents
KW  - Antidepressive Agents
KW  - Antidepressive Agents, Tricyclic
KW  - metabolism
KW  - Antimetabolites
KW  - Anxiety
KW  - drug therapy
KW  - Bromodeoxyuridine
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Citalopram
KW  - Drug Evaluation, Preclinical
KW  - Feeding Behavior
KW  - Hippocampus
KW  - cytology
KW  - Imipramine
KW  - Immunohistochemistry
KW  - Male
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Motor Activity
KW  - Neurons
KW  - Piperidines
KW  - pharmacology
KW  - Receptors, Somatostatin
KW  - antagonists & inhibitors
KW  - Selective Serotonin Reuptake Inhibitors
KW  - X-Rays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1124/jpet.106.109678
ER  -